Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Tailored Therapy - Increase Efficacy of Cetuximab

Share :
Published: 28 Nov 2008
Views: 13657
Rating:
Save
Erbitux and the KRAS Mutation

Tailored Therapy - Increase Efficacy of Cetuximab

Related Videos

Blood tumour mutational burden and response to pembrolizumab plus chemotherapy...
Prof Jair Bar - Sheba Medical Center, Tel-Aviv, Israel
Blood tumour mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer ( Prof Jair Bar - Sheba Medical Center, Tel-Aviv, Israel )
29 Apr 2024
Avelumab plus platinum-based chemotherapy may show some efficacy in patients...
Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece
Avelumab plus platinum-based chemotherapy may show some efficacy in patients with extensive-stage small cell lung cancer ( Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece )
26 Apr 2024
Addition of atezolizumab to chemotherapy after surgery does not improve...
Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA
Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer ( Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA )
26 Apr 2024
A combined PET-MRI scan could improve treatment for patients with early breast...
Dr Rosa Di Micco - San Raffaele Hospital, Milan, Italy
A combined PET-MRI scan could improve treatment for patients with early breast cancer ( Dr Rosa Di Micco - San Raffaele Hospital, Milan, Italy )
26 Apr 2024
EBCC 2024: Addressing inequalities across Europe in access to innovation for...
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr...
EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )
25 Apr 2024
Comment: EBCC 2024 highlights
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr...
Comment: EBCC 2024 highlights ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )
25 Apr 2024
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA )
24 Apr 2024
Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour...
Dr Sujit Nair - Icahn School of Medicine at Mount Sina, New York, USA
Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour hot in prostate cancer ( Dr Sujit Nair - Icahn School of Medicine at Mount Sina, New York, USA )
24 Apr 2024
Avelumab combined with regorafenib shows improved outcome in solid tumours with...
Prof Antoine Italiano - Institute Bergonié, Bordeaux, France
Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures ( Prof Antoine Italiano - Institute Bergonié, Bordeaux, France )
24 Apr 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation